Exagen Inc. (XGN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$2.72
-0.91%
Mkt Cap $76.60M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 10, 2026 | $16.57M | $16.63M | +0.37% | -$0.20 | -$0.20 | +0.00% | — | — |
| Q4 2025 Nov 4, 2025 | $16.54M | $17.24M | +4.28% | -$0.13 | -$0.19 | -46.15% | — | — |
| Q3 2025 Jul 29, 2025 | $16.90M | $17.20M | +1.78% | -$0.18 | -$0.18 | +0.00% | — | — |
| Q2 2025 May 5, 2025 | $14.55M | $15.50M | +6.49% | -$0.20 | -$0.20 | +0.00% | — | — |
| Q1 2025 Mar 11, 2025 | $14.57M | $13.65M | -6.26% | -$0.27 | -$0.20 | +25.93% | — | — |
| Q4 2024 Nov 12, 2024 | $13.53M | $12.51M | -7.58% | -$0.30 | -$0.28 | +6.67% | — | — |
| Q3 2024 Aug 5, 2024 | $13.57M | $15.06M | +11.01% | -$0.36 | -$0.16 | +55.56% | — | — |
| Q2 2024 May 13, 2024 | $13.09M | $14.41M | +10.12% | -$0.40 | -$0.19 | +52.50% | — | — |
| Q1 2024 Mar 18, 2024 | $11.56M | $13.77M | +19.07% | -$0.41 | -$0.31 | +24.39% | — | — |
| Q4 2023 Nov 13, 2023 | $11.68M | $13.42M | +14.86% | -$0.50 | -$0.31 | +38.00% | — | — |
| Q3 2023 Aug 7, 2023 | $10.58M | $14.14M | +33.62% | -$0.48 | -$0.28 | +41.67% | — | — |
| Q2 2023 May 15, 2023 | $9.40M | $11.23M | +19.47% | -$0.52 | -$0.44 | +15.38% | — | — |
| Q1 2023 Mar 20, 2023 | $8.66M | $12.84M | +48.23% | -$0.71 | -$0.58 | +18.31% | — | — |
| Q4 2022 Nov 14, 2022 | $9.04M | $14.73M | +62.81% | -$0.76 | -$0.47 | +38.16% | — | — |
| Q3 2022 Aug 4, 2022 | $12.03M | $8.96M | -25.50% | -$0.55 | -$0.78 | -41.82% | — | — |
| Q2 2022 May 11, 2022 | $10.00M | $10.39M | +3.94% | -$0.59 | -$0.60 | -1.69% | — | — |
| Q1 2022 Mar 22, 2022 | $11.71M | $12.69M | +8.37% | -$0.49 | -$0.42 | +14.29% | — | — |
| Q4 2021 Nov 10, 2021 | $12.54M | $12.25M | -2.27% | -$0.43 | -$0.42 | +2.33% | — | — |
| Q3 2021 Aug 9, 2021 | $12.77M | $12.77M | +0.00% | -$0.50 | -$0.38 | +24.00% | — | — |
| Q2 2021 May 11, 2021 | $10.36M | $10.59M | +2.17% | -$0.46 | -$0.48 | -4.35% | — | — |